All Available Technologies
The current invention is a novel class of compounds that function as KOR antagonists. Because KOR activation has been linked to depression and anxiety related disorders, this novel class of compounds may be used in the development of therapies to treat these mental disorders
This invention consists of a novel composition of matter as well as a process for the efficient conversion of glycerol to lactic acid.
LED traffic signal system which melts snow and ice, preventing loss of visibility.
The invention offers novel composition of matter to be used in treatment of a number of hormone responsive cancers.
Small molecule adjuvants that act as vaccine adjuvants by specifically binding to Toll-Like Receptor-8 (TLR8).
A three-dimensional tumor-in-dish (TID) cell-based assay kit for cancer drug screening that closely replicates actual cellular microenvironments and, therefore, can determine which compounds to move forward for in vivo testing.
This technology is a process for synthesizing low-dimensional hyperthin iron disulfide (FeS2) nanostructures to be used as electrocatalysts for hydrogen production through water-splitting reactions.
A novel anti-metastasis therapy for prostate cancer, utilizing the newly established small-activating RNA (saRNA) technique to up-regulate the expression of the tumor metastasis suppressor gene, dihydropyrimidase-like 3 (DPYSL3).
This device is an improvement on pre-existing technology. It is a nasoenteric feeding tube that is inexpensive, disposable, and designed to give the user more maneuverability and thus a better chance of successfully placing it in the small intestine.